After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Recently, Yahoo Finance discussed the stock, revealing that N/A.
Stocks Info
JAZZ belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Jazz Pharmaceuticals plc is $6.72B. A total of 1.07 million shares were traded on the day, compared to an average of 1.32M shares.
In the most recent transaction, Mulligan Seamus bought 100,000 shares of JAZZ for 98.26 per share on May 09 ’25. After the transaction, the Director now owns 100,000 company shares. In a previous transaction on May 12 ’25, Mulligan Seamus bought 1,621 shares at 103.00 per share. JAZZ shares that Director owns now total 101,621.
Among the insiders who sold shares, COZADD BRUCE C disposed of 1,000 shares on May 01 ’25 at a per-share price of $116.35. This resulted in the Chairman & CEO holding 439,307 shares of JAZZ after the transaction. In another insider transaction, COZADD BRUCE C sold 500 shares at $120.00 per share on May 02 ’25. Company shares held by the Chairman & CEO now total 438,807.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, JAZZ has a high of $148.06 and a low of $95.49.
As of this writing, JAZZ has an earnings estimate of $-5.95 per share for the current quarter. EPS was calculated based on a consensus of 15.0 estimates, with a high estimate of $4.47 per share and a lower estimate of $-9.61.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. JAZZ’s latest balance sheet shows that the firm has $591.45M in Cash & Short Term Investments as of fiscal 2021. There were $6.15B in debt and $809.30M in liabilities at the time. Its Book Value Per Share was $67.75, while its Total Shareholder’s Equity was $3.97B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JAZZ is Buy with a score of 4.63.
